BR112018073492A2 - processo e intermediários para a 6,7-alfa epoxidação de esteroide 4,6-dienos - Google Patents

processo e intermediários para a 6,7-alfa epoxidação de esteroide 4,6-dienos

Info

Publication number
BR112018073492A2
BR112018073492A2 BR112018073492A BR112018073492A BR112018073492A2 BR 112018073492 A2 BR112018073492 A2 BR 112018073492A2 BR 112018073492 A BR112018073492 A BR 112018073492A BR 112018073492 A BR112018073492 A BR 112018073492A BR 112018073492 A2 BR112018073492 A2 BR 112018073492A2
Authority
BR
Brazil
Prior art keywords
intermediates
epoxidation
alpha
diene steroid
relates
Prior art date
Application number
BR112018073492A
Other languages
English (en)
Inventor
Weymouth-Wilson Alexander
WALLIS Laura
Evans Timothy
Komsta Zofia
Original Assignee
Nzp Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nzp Uk Ltd filed Critical Nzp Uk Ltd
Publication of BR112018073492A2 publication Critical patent/BR112018073492A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

a presente invenção refere-se a um processo para a preparação de um composto de fórmula geral (ia): (ia) em que r2, y, r4 e r5 são como definidos aqui, em que a expoxidação é conduzida usando um oxidante e metiltrioxorênio como um catalisador (mereo3). a invenção também se refere a certos compostos de per si. os compostos são intermediários na síntese de ácidos biliares sintéticos.
BR112018073492A 2016-05-18 2017-05-18 processo e intermediários para a 6,7-alfa epoxidação de esteroide 4,6-dienos BR112018073492A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1608776.9A GB201608776D0 (en) 2016-05-18 2016-05-18 Methods and compounds
PCT/GB2017/051389 WO2017199036A1 (en) 2016-05-18 2017-05-18 Process and intermediates for the 6,7-alpha-epoxidation of steroid 4,6-dienes

Publications (1)

Publication Number Publication Date
BR112018073492A2 true BR112018073492A2 (pt) 2019-03-26

Family

ID=56320628

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018073492A BR112018073492A2 (pt) 2016-05-18 2017-05-18 processo e intermediários para a 6,7-alfa epoxidação de esteroide 4,6-dienos

Country Status (15)

Country Link
US (1) US10766921B2 (pt)
EP (1) EP3458467B1 (pt)
JP (1) JP7034094B2 (pt)
KR (1) KR102489565B1 (pt)
CN (1) CN109415404B (pt)
AU (1) AU2017265445B2 (pt)
BR (1) BR112018073492A2 (pt)
CA (1) CA3024283A1 (pt)
DK (1) DK3458467T3 (pt)
EA (1) EA038224B1 (pt)
ES (1) ES2841324T3 (pt)
GB (1) GB201608776D0 (pt)
MX (1) MX2018014130A (pt)
PT (1) PT3458467T (pt)
WO (1) WO2017199036A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201608777D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Compounds
GB201608776D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Methods and compounds
GB201812382D0 (en) 2018-07-30 2018-09-12 Nzp Uk Ltd Compounds
CN111560045A (zh) * 2020-06-23 2020-08-21 江苏佳尔科药业集团股份有限公司 一种以ba为原料合成石胆酸的方法
CN114957368A (zh) * 2021-09-08 2022-08-30 湖南醇康医药科技有限公司 中间体化合物及其制备方法和应用
CN114957372B (zh) * 2021-12-07 2023-10-31 湖南醇康医药科技有限公司 10α-甲基-5,7-二烯甾体化合物和地屈孕酮的制备方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2624748A (en) 1950-09-09 1953-01-06 Upjohn Co Bisnorchola-4, 6-dien-3-one-22-al
IT1088094B (it) 1976-10-14 1985-06-04 Hoffmann La Roche Derivati del pregnano
US4289872A (en) 1979-04-06 1981-09-15 Allied Corporation Macromolecular highly branched homogeneous compound based on lysine units
US5229490A (en) 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
DE3902357A1 (de) 1989-01-27 1990-08-02 Hoechst Ag Verwendung von rheniumorganischen verbindungen zur oxidation von c-c-mehrfachbindungen, darauf basierende oxidationsverfahren und neue rheniumorganische verbindungen
US5166372A (en) 1992-02-07 1992-11-24 Arco Chemical Technology, L.P. Epoxidation process
CA2118130A1 (en) 1992-04-14 1993-10-28 Jean M. J. Frechet Dendritic based macromolecules and method of production
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5723636A (en) 1996-04-12 1998-03-03 National Starch And Chemical Investment Holding Corporation Methyltrioxorhenium-urea hydrogen peroxide epoxidation of olefins
US7138390B2 (en) 2001-03-12 2006-11-21 Intercept Pharmaceuticals Steroids as agonists for FXR
US20090062256A1 (en) 2001-06-01 2009-03-05 Bristol-Myers Squibb Pharma Company LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTION
CA2466027C (en) 2001-11-07 2013-01-08 Nektar Therapeutics Al, Corporation Branched polymers and their conjugates
ITMI20030352A1 (it) 2003-02-27 2004-08-28 Chemi Spa Metodo per la sintesi di metiltriossorenio.
EP1568706A1 (en) 2004-02-26 2005-08-31 Intercept Pharmaceuticals, Inc. Novel steroid agonist for FXR
EP1775304A4 (en) 2004-07-13 2010-04-28 Mitsubishi Chem Corp PROCESS FOR THE PRODUCTION OF STEROIDS
ITMI20050912A1 (it) * 2005-05-19 2006-11-20 Erregierre Spa Processo di preparazione di acidi 3-a-ya(b)-diidrossi-6-a(b)-alchil-5b-colanici
JP2007210888A (ja) 2006-01-12 2007-08-23 Mitsubishi Chemicals Corp ステロイド化合物の製造方法
CA2656320C (en) 2006-06-27 2015-04-28 Intercept Pharmaceuticals, Inc. Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions
WO2010014836A2 (en) 2008-07-30 2010-02-04 Intercept Pharmaceuticals, Inc. Tgr5 modulators and methods of use thereof
JP5639073B2 (ja) 2008-11-19 2014-12-10 インターセプト ファーマシューティカルズ， インコーポレイテッド Ｔｇｒ５モジュレーターおよびその使用方法
JP2013500986A (ja) 2009-07-29 2013-01-10 ザ・ユニバーシティ・オブ・シカゴ 肝臓ｘ受容体アゴニスト
DK3336097T3 (da) 2012-06-19 2020-09-28 Intercept Pharmaceuticals Inc Fremstilling af ikke-krystallinsk obeticholsyre
NZ745013A (en) 2012-10-26 2019-08-30 Intercept Pharmaceuticals Inc Process for preparing bile acid derivatives
MX2015006710A (es) 2012-11-28 2016-01-15 Intercept Pharmaceuticals Inc Tratamiento de las enfermedades pulmonares.
US20140206657A1 (en) 2013-01-18 2014-07-24 City Of Hope Bile acid analog tgr5 agonists
WO2015183794A1 (en) 2014-05-27 2015-12-03 City Of Hope Tgr5 agonist complexes for treating diabetes and cancer
KR102527821B1 (ko) 2014-11-19 2023-05-02 엔제트피 유케이 리미티드 스테로이드 FXR 조절인자를 제조하기 위한 중간체로서의 6α-알킬-6,7-다이온 스테로이드
EA033445B1 (ru) 2014-11-19 2019-10-31 Nzp Uk Ltd 5-бета-6-алкил-7-гидрокси-3-оновые стероиды в качестве промежуточных соединений для получения стероидных модуляторов fxr
CN107108688B (zh) 2014-11-19 2019-10-29 Nzp英国有限公司 作为制备类固醇FXR调节剂的中间体的6α-烷基-3,7-二酮类固醇
EP3221331B1 (en) 2014-11-19 2019-09-18 Nzp Uk Limited 6-alkyl-7-hydroxy-4-en-3-one steroids as intermediates for the production of steroidal fxr modulators
WO2016086115A1 (en) 2014-11-26 2016-06-02 Enanta Pharmaceuticals, Inc. Tetrazole derivatives of bile acids as fxr/tgr5 agonists and methods of use thereof
CN105348365A (zh) 2014-12-03 2016-02-24 四川百利药业有限责任公司 一种胆酸衍生物及其制备方法、药物组合物和用途
GB201608777D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Compounds
GB201608776D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Methods and compounds
GB201608779D0 (en) * 2016-05-18 2016-06-29 Dextra Lab Ltd Methods and compounds

Also Published As

Publication number Publication date
AU2017265445B2 (en) 2020-12-03
EP3458467A1 (en) 2019-03-27
KR102489565B1 (ko) 2023-01-17
PT3458467T (pt) 2021-01-05
US20190309012A1 (en) 2019-10-10
AU2017265445A1 (en) 2018-11-15
MX2018014130A (es) 2019-04-29
ES2841324T3 (es) 2021-07-08
WO2017199036A1 (en) 2017-11-23
KR20190007011A (ko) 2019-01-21
EA038224B1 (ru) 2021-07-27
CN109415404A (zh) 2019-03-01
EP3458467B1 (en) 2020-09-30
JP2019516729A (ja) 2019-06-20
GB201608776D0 (en) 2016-06-29
EA201892516A1 (ru) 2019-05-31
CA3024283A1 (en) 2017-11-23
DK3458467T3 (da) 2020-12-14
JP7034094B2 (ja) 2022-03-11
US10766921B2 (en) 2020-09-08
CN109415404B (zh) 2022-08-26

Similar Documents

Publication Publication Date Title
BR112018073492A2 (pt) processo e intermediários para a 6,7-alfa epoxidação de esteroide 4,6-dienos
BR112014030365A2 (pt) síntese de composto antiviral
BR112016028773A2 (pt) processos para preparação de compostos antivirais
BR112018073490A2 (pt) 6.7.beta-epóxidos esteroides como intermediários químicos
BR112018001400A2 (pt) compostos, processo para a síntese dos compostos, composição, utilização de um composto, método para o combate dos fungos e sementes
BR112017020993A2 (pt) compostos, processo para a síntese de compostos, composição, uso de um composto da fórmula i, método para combater fungos fitopatogênicos, e, semente.
HN2011000341A (es) Compuestos derivados de sulfonamidas, composiciones farmaceuticos y proceso de preparacion de los mismos
BR112017027414A2 (pt) Derivados hidroxiéster, processo para prepará- los e composições farmacêuticas os contendo
BR112017010319A2 (pt) esteroides 6-alquil-7-hidróxi-4-em-3-ona como intermediários para a produção de modula¬dores fxr esteroidal
BR112018073488A2 (pt) intermediários para a síntese de derivados de ácido biliar, em particular de ácido obeticólico
BR112016029333A2 (pt) síntese de compostos de carbamoilpiridona policíclico
ECSP10010619A (es) Derivados de indazoles sustituidos con fenilo o piridinilo
BR112018016887A2 (pt) método para fabricação de ciclododecaenxofre.
BR112019006571A2 (pt) derivados de éter de isoxazolila como gaba a alfa5 pam
BR112018006519A2 (pt) compostos de fórmula, processo para a síntese de compostos, compostos intermediários x, composição, utilização de um composto de fórmula, método para o combate de fungos e semente
CL2018001210A1 (es) Compuestos de criptoficina novedosos y productos conjugados, su preparación y su uso terapéutico.
BR112016018851A8 (pt) processo para fornecer um composto de fórmula (iv)
BR112012013582A2 (pt) processo para síntese de intermediários úteis para a produção de compostos de indazol e azaindazol substituídos
UY31577A1 (es) Proceso para la preparacion de 6-sustituido-1-(2h)-isoquinolinonas
CU20120065A7 (es) Derivado de 4-[etil(dimetil)amonio] butanoato para el tratamiento de enfermedades cardiovasculares y sus métodos de obtención
BR112016018418A2 (pt) Composto, uso do mesmo, e composição farmacêutica
BR112018074287A2 (pt) processo para preparação de eribulina e intermediários da mesma
UY35766A (es) Proceso industrial para la síntesis de ingredientes activos esteroides
BR112013004546A2 (pt) processo para produção de tmhq.
BR112015014440A2 (pt) processo para a produção de uma solução aquosa purificada de peróxido de hidrogênio

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C07J 9/00 , C07J 71/00

Ipc: C07J 9/00 (2006.01), C07J 71/00 (2006.01), A61P 1/

B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]